Cramer wonders how the markets that were so loved just a few weeks ago could be so hated this week.
Cramer likes Kinder Morgan's yield and Isis Pharmaceuticals' pipeline but he's not crazy about Valero Energy.
Disney and Celgene have bankable CEOs while Halogen Therapeutics is involved in some promising treatments.
Investors can either find stocks they like and watch them like a hawk or sell into strength and buy into weakness, Cramer says.
Cramer sees Oracle climbing, doesn't like Outfront Media and worries about Corning in the short term.
Cramer remains a big fan of Alcoa and thinks Acorda Therapeutics is exactly what investors should be looking for in a growth stock.
The restaurants and the biotechs tried their best to save us but it just wasn't enough, Cramer says.
Cramer was bearish on Cliffs Natural Resources, Royal Dutch Shell and Halozyme Therapeutics.
Cramer says to buy, buy, buy Morgan Stanley and Agenus is a red-hot biotech.
Earnings season is back and Cramer will be watching Alcoa and CSX, among others.